Exhibit 99.1
Joint Filing Agreement
The undersigned hereby agree that the Statement on Schedule 13G dated March 1, 2019 with respect to the Common Stock, $0.001 par value of Catalyst Biosciences, Inc., and any further amendments thereto executed by each and any of the undersigned shall be filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.
Dated: March 1, 2019
CCUR HOLDINGS, INC. | |||
By: | /s/ Wayne Barr, Jr. | ||
Name: | Wayne Barr, Jr. | ||
Title: | CEO, President and Executive Chairman | ||
JDS1, LLC | |||
By: | /s/ Julian Singer | ||
Name: | Julian Singer | ||
Title: | Managing Member | ||
ACTINIUM CAPITAL, LP | |||
By: | Actinium Capital GP LLC, its general partner | ||
By: | /s/ Julian Singer | ||
Name: | Julian Singer | ||
Title: | Managing Member | ||
ACTINIUM CAPITAL GP LLC | |||
By: | /s/ Julian Singer | ||
Name: | Julian Singer | ||
Title: | Managing Member | ||
/s/ Wayne Barr, Jr. | |||
Wayne Barr, Jr. | |||
/s/ David S. Oros | |||
David S. Oros | |||
/s/ Erik Oros | |||
ERIK Oros | |||
/s/ Julian Singer | |||
Julian Singer |